<DOC>
	<DOC>NCT00127179</DOC>
	<brief_summary>The purpose of this trial is to determine the efficacy and safety of an investigational drug in patients with benign prostatic hyperplasia.</brief_summary>
	<brief_title>A Study of an Investigational Study Drug for Benign Prostatic Hyperplasia (0906-140)</brief_title>
	<detailed_description />
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<mesh_term>Finasteride</mesh_term>
	<criteria>Patients with benign prostatic hyperplasia Patients who are suspected to be suffering from prostatic cancer</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>